The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of busulfan-melphalan high dose chemotherapy consolidation (BuMel) in localized high-risk Ewing sarcoma (ES): Results of EURO-EWING 99-R2 randomized trial (EE99R2Loc).
 
Jeremy Whelan
No Relationships to Disclose
 
Marie-Cecile Le Deley
No Relationships to Disclose
 
Uta Dirksen
No Relationships to Disclose
 
Ian Robert Judson
Honoraria - Ariad; Bayer; GlaxoSmithKline; GlaxoSmithKline; Merck Serono
Consulting or Advisory Role - ARIAD; Bayer; GlaxoSmithKline
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Merck Serono
 
Douglas S. Hawkins
No Relationships to Disclose
 
Hendrik Van Den Berg
No Relationships to Disclose
 
Ruth Ladenstein
No Relationships to Disclose
 
Jarmila Kruseova
No Relationships to Disclose
 
Andreas Ranft
No Relationships to Disclose
 
Susanne Amler
No Relationships to Disclose
 
Nathalie Gaspar
No Relationships to Disclose
 
Valerie Laurence
No Relationships to Disclose
 
Gwenael Le Teuff
No Relationships to Disclose
 
Perrine Marec-Berard
No Relationships to Disclose
 
Bernadette Brennan
No Relationships to Disclose
 
Keith Wheatley
No Relationships to Disclose
 
Bruce Morland
No Relationships to Disclose
 
Sandrine Marreaud
No Relationships to Disclose
 
Heribert Juergens
No Relationships to Disclose
 
Odile Oberlin
No Relationships to Disclose